These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 394864)

  • 41. Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes.
    Valagussa P; Tess JD; Rossi A; Tancini G; Banfi A; Bonadonna G
    Breast Cancer Res Treat; 1981; 1(4):349-56. PubMed ID: 6897368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer.
    Carter SK
    Cancer Chemother Pharmacol; 1980; 4(3):147-63. PubMed ID: 6772333
    [No Abstract]   [Full Text] [Related]  

  • 43. Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer.
    Brincker H; Mouridsen HT; Andersen KW
    Breast Cancer Res Treat; 1983; 3(1):91-5. PubMed ID: 6347278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
    Bonadonna G; Valagussa P; Rossi A; Tancini G; Brambilla C; Zambetti M; Veronesi U
    Breast Cancer Res Treat; 1985; 5(2):95-115. PubMed ID: 3839424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
    Goldhirsch A; Gelber R
    NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer.
    Bonadonna G; Valagussa P; Tancini G; Rossi A; Brambilla C; Zambetti M; Bignami P; Di Fronzo G; Silvestrini R
    NCI Monogr; 1986; (1):45-9. PubMed ID: 3534590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer.
    Tancini G; Bajetta E; Marchini S; Valagussa P; Bonadonna G; Veronesi U
    Cancer Clin Trials; 1979; 2(4):285-92. PubMed ID: 394864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].
    Nagykálnai T
    Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.